Format

Send to

Choose Destination
BMJ. 2015 Nov 3;351:h5829. doi: 10.1136/bmj.h5829.

Basing approval of drugs for type 2 diabetes on real world outcomes.

Author information

1
Section of Clinical Medicine and Ageing, University of Sussex, Guildford GU2 7PX, UK.
2
St George's Vascular Institute, Division of Cardiovascular Sciences, St George's, University of London, London, UK.
PMID:
26530057
DOI:
10.1136/bmj.h5829
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center